Gastroesophageal reflux disease

JAMA

Volumn 276, Issue 12, 1996, Pages 983-988

  Kahrilas, Peter J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CIMETIDINE; CISAPRIDE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NIZATIDINE; OMEPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RANITIDINE;

ANTIREFLUX OPERATION; ASTHMA; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; ESOPHAGUS CANCER; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNGITIS; PHARYNGITIS; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; SUBGLOTTIC STENOSIS;

EID: 0029845265     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.12.983     Document Type: Review

References (66)

1. Winkelstein A. Peptic esophagitis: a new clinical entity. JAMA. 1935;104:906-909.
2. Allison PR. Peptic ulcer of the esophagus. J Tharac Surg. 1946;15:308-317.
3. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976;21:953-956.
4. Hirsehowitz BI. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology. 1991;101:1149-1158.
5. Orlando RC. Esophageal epithelial defenses against acid injury. Am J Gastroenterol. 1994;89:S48-S52.
6. Tibbling L. Epidemiology of gastro-oesophageal reflux disease. Scand J Gastroenterol. 1984;19(suppl 106):14-18.
7. Sontag SJ. Gastroesophageal reflux disease. Aliment Pharmacol Ther. 1993;7:293-312.
8. Bell NJV, Hunt RH. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease. Gut 1992;33:118-124.
9. Richter JE, Long JF. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double blind study. Am J Gastroenterol. 1995;90:423-430.
10. Dorsch E, Jones J, Padgett C, Jennings D, Greski P, Lansoprazole Study Group. Lansoprazole heals moderate to severe reflux esophagitis. Am J Gastroenterol. 1991;86(suppl 9):1294.
11. Sontag SJ. The medical management of reflux esophagitis; role of antacids and acid inhibition. Gastroenterol Clin North Am. 1990;19:683-712.
12. Hatlebakk JG, Berstad A, Carling L, et al. Lansoprazole versus omeprazole in short-term treatment of reflux esophagitis: results of a Scandinavian multicentre trial. Scand J Gastroenterol. 1993;28:224-228.
13. +-ATPase inhibitor: a controlled, double-blind study. Am J Gastroenterol. 1993;88:1212-1217.
14. Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, et al. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med. 1994;121:161-167.
15. Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Arch Intern Med, 1989;149:2486-2492.
16. Galmiche JP, Brandsätter, Evreux M, Hentschel E. Combined therapy with cisapride and cimetidine in severe oesophagitis: a double blind controlled trial. Gut. 1988;29:675-681.
17. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology. 1988;95: 903-912.
18. Dent J, Yeomans ND, Mackinnon M, et al. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis: a controlled double blind trial of their efficacy and safety. Gut. 1994;35:590-598.
19. Vigneri S, Termini R, Leandro G, et al. A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med. 1995;333:1106-1110.
20. Robinson M, Lanza F, Avner D, Haber M. Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole: a randomized double blind placebo-controlled trial. Ann Intern Med. 1996; 124:859-867.
21. Freston JW. Omeprazole, hypergastrinemia, and gastric carcinoid tumors. Ann Intern Med. 1994;121: 232-234.
22. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996;334:1018-1022.
23. Peters JH, DeMeester TR. Minimally Invasive Surgery of the Foregut. St Louis, Mo: Quality Medical Publishing; 1994.
24. Hinder RA, Filipi CJ, Wetscher G, DeMeester TR, Perdikis G. Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg. 1994;220:472-481.
25. Trus TL, Laycock WS, Branum G, Waring JP, Mauren S, Hunter JG. Intermediate follow-up of laparoscopic antireflux surgery. Am J Surg. 1996;171: 32-35.
26. Spechler SJ, Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med. 1992;326:786-792.
27. Cameron AJ, Higgins JA. Linear gastric erosion, a lesion associated with large diaphragmatic hernia and chronic blood loss anemia. Gastroenterology. 1986;91:338-342.
28. Wesdorp IC, Bartelsman JF, den Hartog Jager FC, Huibregtse K, Tytgat GN. Results of conservative treatment of benign esophageal stricture: a follow-up study in 100 patients. Gastroenterology. 1982;82:487-493.
29. Patterson DJ, Graham DY, Smith JL, et al. Natural history of benign esophageal stricture treated by dilatation. Gastroenterology. 1983;85:346-350.
30. Mercer CD, Hill LD. Surgical management of peptic esophageal stricture: twenty-year experience. J Thorac Cardiovasc Surg. 1986;91:371-378.
31. 2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology. 1994;106:907-915.
32. Morson BC, Sobin LH, Grundmann E, Johansen A, Nagayo T, Serck-Hanssen A. Pre-cancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol. 1980;33:711-721.
33. Sampliner RE. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. Am J Gastroenterol. 1994;89:1844-1848.
34. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med. 1986;315:362-371.
35. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med. 1985;313:857-859.
36. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RJ. Prevaience of metaplasia at the gastrooesophageal junction. Lancet. 1994;344:1533-1536.
37. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci. 1992;37:137-143.
38. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265:1287-1289.
39. Blot WJ, Devesa SS, Fraumeni JF. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA. 1993;270:1320.
40. Clark GWB, Smyrk TC, Burdiles P, et al. Is Barrett's metaplasia the Source of adenocarcinomas of the cardia? Arch Surg. 1994;129:609-614.
41. Sampliner RE, Jaffe P. Malignant degeneration of Barrette's esophagus; the role of laser ablation and photodynamic therapy. Dis Esophagus. 1995;8:104-108.
42. Fennerty MB, Sampliner RE, Garewal HS. Review article: Barrett's esophagus - cancer risk, biology and therapeutic management. Aliment Pharmacol Ther. 1993;7:389-345.
43. Dent J, Bremner CG, Collen MJ, Haggitt RC, Spechler SJ. Barrett's Oesophagus; Working Party Reports of the Ninth World Congresses of Gastroenterology. Melbourne, Australia: Blackwell Scientific Publications; 1990:17-26.
44. Ing AJ, Ngu MC, Breslin ABX. The pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med. 1994;149:160-167.
45. Schroeder PL, Filler SJ, Ramierez B, Lazarchik DA, Vaezi MF, Richter JE. Dental erosions and acid reflux disease. Ann Intern Med. 1995;122:809-815.
46. Sontag SJ, O'Connell S, Khandelwal S, et al. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology. 1990;99:613-620.
47. Harding SM, Richter JE, Guzzo MR, Schan CA, Alexander RW, Bradley LA. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med. 1996;100:395-405.
48. Mansfield LE, Stein MR. Gastroesophageal reflux and asthma: a possible reflex mechanism. Ann Allergy. 1978;41:224-226.
49. Tuchman DN, Boyle JT, Pack AI, et al. Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology. 1984;87:872-881.
50. Crausaz FM, Favez G. Aspiration of solid food particles into the lungs of patients with gastroesophageal reflux and chronic bronchial disease. Chest. 1988;93:376-378.
51. Larrain A, Carrasco E, Galleguillos F, Sepulveda R, Pope CE. Medical and surgical treatment of nonallergic asthma associated with gastroesophageal reflux. Chest. 1991;99:1330-1335.
52. Jacob P, Kahrilas PJ, Herzon G. Proximal esophageal pH-metry in patients with 'reflux laryngitis.' Gastroenterology. 1991;100:305-310.
53. Kouiman JA. The otolaryngologic manifestations of gastroesophageal reflux disease. Laryngoscope. 1991;10(suppl 53):1-78.
54. Shaker E, Milbrath M, Ren J, et al. Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology. 1995;109:1575-1572.
55. Cote DN, Miller RH. The association of gastroesophageal reflux and otolaryngologic disorders. Compr Ther. 1995;21:80-84.
56. Gaynor EB. Gastroesophageal reflux as an etiologic factor in laryngeal complications of intubation. Laryngoscope. 1988;98:972-979.
57. Cherry J, Margulies SI. Contact ulcer of the larynx. Laryngoscope. 1968;78:1937-1940.
58. Kambic V, Radsel Z. Acid posterior laryngitis, aetìology, histology, diagnosis and treatment. J Laryngol Otol. 1984;98:1237-1240.
59. Kamel PL, Hanson D, Kahrilas PJ. Prospective trial of omeprazoie in the treatment of posterior laryngitis. Am J Med. 1994;96:321-326.
60. Hanson DG, Kamel PL, Kahrilas PJ. Outcomes of anti-reflux therapy in the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol. 1995;104:550-555.
61. Wydner EL. Stellman SD. Comparative epidemiology of tobacco-related cancers. Cancer Res. 1977; 37:4608-4622.
62. Olsen NR. Effects of stomach acid on the larynx. Proc Am Laryngol Assoc. 1983;104:108-112.
63. Morrison MD. Is chronic gastroesophageal reflux a causative factor in glottic carcinoma? Otolaryngol Head Neck Surg. 1988;99:370-373.
64. Ward PH, Hanson DG. Reflux as an etiologic factor of carcinoma of the laryngopharynx. Laryngoscope. 1988;98:1195-1199.
65. Kahrilas PJ, Clouse RE, Hogan WJ. American Gastroenterological Association technical review on the clinical use of esophageal manometry. Gastroenterology. 1994;107:1865-1884.
66. Kahrilas PJ, Quigley EMM. Clinical esophageal pH monitoring, a technical review for practice guideline development. Gastroenterology. 1996;110:1982-1996.